Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Leukaemia Foundation joins forces with blood cancer survivor Briony Benjamin to raise awareness of lymphoma

Leukaemia Foundation 3 mins read

On World Lymphoma Awareness Day (September 15), the Leukaemia Foundation is joining forces with Gold Coast author, content creator, motivational speaker and inspiring lymphoma survivor, Briony Benjamin.   

As a national ambassador for the Leukaemia Foundation, Briony is hoping to raise much-needed awareness of lymphoma - the most diagnosed form of blood cancer in Australia – and is encouraging anyone impacted by the disease to reach out to the Leukaemia Foundation for support.   

With over 65,200 Australians currently living with lymphomai, World Lymphoma Awareness Day provides an opportunity for the Leukaemia Foundation to educate people on the signs and symptoms of the disease, which can often be subtle and difficult to recognise.  

Common lymphoma symptoms include painless lumps around the lymph nodes usually in the neck, armpit or groin that may be dismissed as harmless. Other symptoms are night sweats, recurrent infections or fevers, and even itchy skin. 

As someone who was misdiagnosed several times before eventually being told she had lymphoma, Briony believes that because the disease can be difficult to spot, it’s especially important to listen to your body and to act when something doesn’t feel right. 

The Leukaemia Foundation encourages Australians to speak to your GP if you have ongoing symptoms that can’t be explained. The sooner that a blood cancer diagnosis occurs, the greater chance people have of beating the disease. 

Anyone impacted by lymphoma, or any type of blood cancer can contact Australia’s blood cancer support line Monday to Friday via calling 1800 620 420 or visit   


  • Briony is a Gold Coast based storyteller, content creator, motivational speaker and author of the book and journal ‘Life is Tough But So Are You’.  

  • Briony was a healthy and fit 31-year-old before she was diagnosed with stage four Hodgkin lymphoma in 2018, a shock diagnosis which instantly turned her life upside down. 

  • Briony was thrown into life-saving treatment almost immediately including months of grueling chemotherapy where she lost her hair. 

  • After eventually being declared cancer-free, it took Briony a long time to recover physically and emotionally from her blood cancer experience.  

  • She is now a healthy and thriving blood cancer survivor and is pregnant with her first child due in October. 

  • Briony is available for interviews to speak about her own first-hand experience with lymphoma and what she hopes to achieve in collaboration with Leukaemia Foundation on World Lymphoma Awareness Day.  

Please contact the Leukaemia Foundation media team to interview Briony Benjamin, and/or a Leukaemia Foundation spokesperson at 

Lymphoma – facts and figuresii: 

  • Lymphoma is the most common type of blood cancer in Australia. 

  • In 2023, 7,403 Australians will be diagnosed with lymphoma. This is projected to more than double to reach 17,171 people per year by 2035.  

  • Currently, 65,233 Australians are living with lymphoma.  


About us:

About the Leukaemia Foundation: The Leukaemia Foundation has been named Australia's most reputable cancer charity and third most reputable charity overall. We stand with Australia to help cure and conquer blood cancer – with care. Together we are attacking every blood cancer, from every direction, in every way we can. We stand beside every Australian to be their voice and their someone-to-turn to, fighting to get them access to the best care. We also accelerate research that is delivering rapid advancements in blood cancer diagnosis and treatments. Plus, we provide services and support that empower people living with any blood cancer to live well after diagnosis. You can learn more about the Leukaemia Foundation and blood cancer at 

Contact details:

Please contact the Leukaemia Foundation media team to interview Briony Benjamin, and/or a Leukaemia Foundation spokesperson at 


More from this category

  • Medical Health Aged Care
  • 29/05/2024
  • 17:07
JJP Biologics

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)

JJP Biologics has received a positive conclusion on the Clinical Trial Application assessment for a Phase I Study of a potential first-in-class anti-CD89 antagonist,…

  • Contains:
  • Medical Health Aged Care
  • 29/05/2024
  • 11:54

Long-term prescription opioid use after hospital declining: study

UNSW Sydney medical researchers have shed light on post-hospital prescription opioid use. A large, linked data study has detailed the scale of prescription opioid…

  • Contains:
  • Medical Health Aged Care
  • 29/05/2024
  • 11:45
Cleo Diagnostics Limited ASX.COV

Cleo’s Ovarian Cancer Blood Test Outperforms Current Clinical Benchmark

Highlights A benchmarking study comparing CLEO’s ovarian cancer blood test against ultrasound has been published in scientific journal “Cancers” The study confirmed that CLEO’s initial test for the surgical triage market:– Significantly outperforms current clinical workflows that use CA125 and ultrasound to predict malignancy;– Correctly detected 90% of early-stage cancers compared to only 50% using standard workflows; and– Can be easily adopted for use into clinical practice. The superior performance of CLEO’s test now compared to all current routine clinical tools shows the significant global potential for the test in clinical decision making prior to surgical intervention. MELBOURNE, AUSTRALIA, 29…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.